C23H30N4O9.C2HF3O2
Neat
506.51 114.02
1957236-21-3; E3 ligase Ligand-Linker Conjugates 14; Thalidomide-O-amido-PEG3-C2-NH2 (TFA); Thalidomide-O-amido-PEG3-C2-NH2 TFA; MFCD31560482; N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-2-[2-(2, 6-dioxopiperidin-3-yl)-1, 3-dioxoisoindol-4-yl]oxyacetamide;2, 2, 2-trifluoroacetic acid; N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-2-[2-(2, 6-dioxo-3-piperidyl)-1, 3-dioxo-isoindolin-4-yl]oxy-acetamide;2, 2 and 2-trifluoroacetic acid; orb1299534; SCHEMBL17873786; TQP0425; BLYRZYHKZRITLJ-UHFFFAOYSA-N; C25H31F3N4O11; EX-A3863; AKOS037653312; AT11913; CS-7753; AC-37728; DA-72964; SY356771; Thalidomide-O-amido-PEG3-amine TFA salt
N-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]ethyl]-2-[2-(2, 6-dioxopiperidin-3-yl)-1, 3-dioxoisoindol-4-yl]oxyacetamide;2, 2 and 2-trifluoroacetic acid
InChI=1S/C23H30N4O9.C2HF3O2/c24-6-8-33-10-12-35-13-11-34-9-7-25-19(29)14-36-17-3-1-2-15-20(17)23(32)27(22(15)31)16-4-5-18(28)26-21(16)30;3-2(4,5)1(6)7/h1-3,16H,4-14,24H2,(H,25,29)(H,26,28,30);(H,6,7)